Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Citi
Express Scripts
Farmers Insurance
Cantor Fitzgerald
Merck
Chubb
Baxter
Federal Trade Commission

Generated: July 19, 2018

DrugPatentWatch Database Preview

Alseroxylon - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for alseroxylon and what is the scope of alseroxylon patent protection?

Alseroxylon
is the generic ingredient in two branded drugs marketed by Novartis and 3M, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Summary for alseroxylon
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Bulk Api Vendors: 5
Patent Applications: 3
DailyMed Link:alseroxylon at DailyMed
Synonyms for alseroxylon
1, N-(2-aminoethyl)-N'-[2-[(2-aminoethyl)amino]ethyl]-, polymer with (chloromethyl)oxirane
1,2-Ethanediamine, N-(2-aminoethyl)-N'-(2-((2-aminoethyl)amino)ethyl)-, polymer with (chloromethyl)oxirane
1,2-Ethanediamine, N1-(2-aminoethyl)-N2-(2-((2-aminoethyl)amino)ethyl)-, polymer with 2-(chloromethyl)oxirane
11006-60-3
26658-42-4
50925-79-6
8001-95-4
AC1L1XU1
Alseroxylon [JAN]
C06925
Cholestabyl
COLESTIPOL
Colestipol [INN:BAN]
Colestipolum
Colestipolum [INN-Latin]
Copolymer of bis(2-aminoethyl)amine and 2-(chloromethyl)oxirane
DB00375
DR000988
Egalin
Epichlorohydrin-tetraethylenepentamine copolymer
Epichlorohydrin-tetraethylenepentamine polymer
Epichlorohydrin, polymer with tetraethylenepentamine
Epichlorohydrin, tetraethylenepentamine polymer
epichlorohydrin; tetraethylenepentamine
GMRWGQCZJGVHKL-UHFFFAOYSA-N
K50N755924
LP083058
LS-182744
N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine; 2-(chloromethyl)oxirane
NSC 147003
NSC-147003
NSC147003
Oxirane, (chloromethyl)-, polymer with N-(2-aminoethyl)-N'-(2-((2-aminoethyl)amino)ethyl-1,2-ethanediamine
Oxirane, polymer with N-(2-aminoethyl)-N'-[2-[(2-aminoethyl)amino]ethyl]-1,2-ethanediamine
Poly(epichlorohydrin-co-tetraethylenepentamine)
Propane, 1-chloro-2,3-epoxy-, polymer with tetraethylenepentamine
Rau-Tab
Rautensin
SCHEMBL1649962
Tetraethylenepentamine epichlorohydrin polymer
Tetraethylenepentamine-epichlorohydrin copolymer
Tetraethylenepentamine-epichlorohydrin polymer
Tetraethylenepentamine, cross-linked with epichlorohydrin
Tetraethylenepentamine, polymer with 1-chloro-2,3-epoxypropane
Tetraethylenepentamine, polymer with 1-chloro-2,3-epoxypropane (8CI)
Tetraethylenepentamine,3-epoxypropane
U 26,597A
U 26597A
UNII-K50N755924

US Patents and Regulatory Information for alseroxylon

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m RAUWILOID alseroxylon TABLET;ORAL 008867-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis RAUTENSIN alseroxylon TABLET;ORAL 009215-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
US Department of Justice
Federal Trade Commission
Deloitte
US Army
Daiichi Sankyo
Cipla
Citi
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.